232 related articles for article (PubMed ID: 26671728)
1. Possible Antipruritic Mechanism of Cyclosporine A in Atopic Dermatitis.
Ko KC; Tominaga M; Kamata Y; Umehara Y; Matsuda H; Takahashi N; Kina K; Ogawa M; Ogawa H; Takamori K
Acta Derm Venereol; 2016 Jun; 96(5):624-9. PubMed ID: 26671728
[TBL] [Abstract][Full Text] [Related]
2. Topically applied semaphorin 3A ointment inhibits scratching behavior and improves skin inflammation in NC/Nga mice with atopic dermatitis.
Negi O; Tominaga M; Tengara S; Kamo A; Taneda K; Suga Y; Ogawa H; Takamori K
J Dermatol Sci; 2012 Apr; 66(1):37-43. PubMed ID: 22381253
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy of tacrolimus and cyclosporine A in a murine model of dinitrofluorobenzene-induced atopic dermatitis.
Yamashita H; Ito T; Kato H; Asai S; Tanaka H; Nagai H; Inagaki N
Eur J Pharmacol; 2010 Oct; 645(1-3):171-6. PubMed ID: 20674565
[TBL] [Abstract][Full Text] [Related]
4. Differences in therapeutic effects of topically applied corticosteroid and tacrolimus on atopic dermatitis-like symptoms in NC/Nga mice.
Noguchi A; Tominaga M; Takahashi N; Matsuda H; Kamata Y; Umehara Y; Ko KC; Suga Y; Ogawa H; Takamori K
J Dermatol Sci; 2017 Apr; 86(1):54-62. PubMed ID: 28069324
[TBL] [Abstract][Full Text] [Related]
5. Topical E6005, a novel phosphodiesterase 4 inhibitor, attenuates spontaneous itch-related responses in mice with chronic atopy-like dermatitis.
Andoh T; Yoshida T; Kuraishi Y
Exp Dermatol; 2014 May; 23(5):359-61. PubMed ID: 24645735
[TBL] [Abstract][Full Text] [Related]
6. New therapies for controlling atopic itch.
Furue M; Kadono T
J Dermatol; 2015 Sep; 42(9):847-50. PubMed ID: 26332459
[TBL] [Abstract][Full Text] [Related]
7. Hypochlorous acid is antipruritic and anti-inflammatory in a mouse model of atopic dermatitis.
Fukuyama T; Martel BC; Linder KE; Ehling S; Ganchingco JR; Bäumer W
Clin Exp Allergy; 2018 Jan; 48(1):78-88. PubMed ID: 29028288
[TBL] [Abstract][Full Text] [Related]
8. Neurotropin suppresses itch-related behavior in NC/Nga mice with atopic dermatitis-like symptoms.
Kamo A; Tominaga M; Matsuda H; Kina K; Kamata Y; Umehara Y; Ogawa H; Takamori K
J Dermatol Sci; 2016 Mar; 81(3):212-5. PubMed ID: 26725918
[No Abstract] [Full Text] [Related]
9. Oral administration of bepotastine besilate suppressed scratching behavior of atopic dermatitis model NC/Nga mice.
Tanizaki H; Kambe N; Nakamura Y; Tanaka A; Matsuda H; Miyachi Y
Int Arch Allergy Immunol; 2008; 145(4):277-82. PubMed ID: 18004068
[TBL] [Abstract][Full Text] [Related]
10. Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice.
Arai I; Takaoka A; Hashimoto Y; Honma Y; Koizumi C; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakanishi Y; Sakurai T; Tanami T; Yagi M; Ono N; Nakaike S
Eur J Pharmacol; 2007 Feb; 556(1-3):207-14. PubMed ID: 17141215
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone.
Inagaki N; Shiraishi N; Igeta K; Itoh T; Chikumoto T; Nagao M; Kim JF; Nagai H
Eur J Pharmacol; 2006 Sep; 546(1-3):189-96. PubMed ID: 16914137
[TBL] [Abstract][Full Text] [Related]
12. Topical Application of ASN008, a Permanently Charged Sodium Channel Blocker, Shows Robust Efficacy, a Rapid Onset, and Long Duration of Action in a Mouse Model of Pruritus.
Ramachandran R; Thompson SK; Malkmus S; Mieda T; Lin JH; Gupta S; Yaksh TL
J Pharmacol Exp Ther; 2020 Sep; 374(3):521-528. PubMed ID: 32616515
[TBL] [Abstract][Full Text] [Related]
13. Antipruritic effects of the probiotic strain LKM512 in adults with atopic dermatitis.
Matsumoto M; Ebata T; Hirooka J; Hosoya R; Inoue N; Itami S; Tsuji K; Yaginuma T; Muramatsu K; Nakamura A; Fujita A; Nagakura T
Ann Allergy Asthma Immunol; 2014 Aug; 113(2):209-216.e7. PubMed ID: 24893766
[TBL] [Abstract][Full Text] [Related]
14. [Effect of TRK-820, a selective kappa opioid receptor agonist, on scratching behavior in an animal model of atopic dermatitis].
Nakao K; Ikeda K; Kurokawa T; Togashi Y; Umeuchi H; Honda T; Okano K; Mochizuki H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Apr; 28(2):75-83. PubMed ID: 18516986
[TBL] [Abstract][Full Text] [Related]
15. Antipruritic and antidermatitic effect of extract and compounds of Impatiens balsamina L. in atopic dermatitis model NC mice.
Oku H; Ishiguro K
Phytother Res; 2001 Sep; 15(6):506-10. PubMed ID: 11536380
[TBL] [Abstract][Full Text] [Related]
16. Antipruritic mechanisms of topical E6005, a phosphodiesterase 4 inhibitor: inhibition of responses to proteinase-activated receptor 2 stimulation mediated by increase in intracellular cyclic AMP.
Andoh T; Kuraishi Y
J Dermatol Sci; 2014 Dec; 76(3):206-13. PubMed ID: 25458869
[TBL] [Abstract][Full Text] [Related]
17. Antipruritic effects of TRPV1 antagonist in murine atopic dermatitis and itching models.
Yun JW; Seo JA; Jang WH; Koh HJ; Bae IH; Park YH; Lim KM
J Invest Dermatol; 2011 Jul; 131(7):1576-9. PubMed ID: 21471988
[No Abstract] [Full Text] [Related]
18. Extracts of the leaves of Pyrus ussuriensis Maxim. Alleviate itch sensation via TSLP-dependent manner in mouse models of atopic dermatitis.
Kim BH; Lee WJ; Sanjel B; Cho K; Son YK; Park HY; Kim SY; Shim WS
Physiol Behav; 2019 Oct; 210():112624. PubMed ID: 31325512
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the spontaneous scratching behavior by NC/Nga mice: a possible approach to evaluate antipruritics for subjects with atopic dermatitis.
Takano N; Arai I; Kurachi M
Eur J Pharmacol; 2003 Jun; 471(3):223-8. PubMed ID: 12826242
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal Minocycline Suppresses Itch-Related Behavior and Improves Dermatitis in a Mouse Model of Atopic Dermatitis.
Torigoe K; Tominaga M; Ko KC; Takahashi N; Matsuda H; Hayashi R; Ogawa H; Takamori K
J Invest Dermatol; 2016 Apr; 136(4):879-881. PubMed ID: 26827761
[No Abstract] [Full Text] [Related]
[Next] [New Search]
